Eyenovia, Inc. announced that Bren Kern, who currently serves as Eyenovia's Senior Vice President of Manufacturing and Operations, has been promoted to Chief Operating Officer and Corporate Vice President, effective January 1, 2023. Mr. Kern has spent his career helping companies transition from research and development entities into scaled commercial manufacturing organizations. Over the past 20 years, he honed his skills by leading product optimization, supporting regulatory approvals (510K & PMA) and establishing cGMP compliant manufacturing solutions worldwide.

Prior to joining the Company, Mr. Kern held leadership positions in multiple medical device and diagnostic companies, including Hound Labs, Inc., Second Source Medical LLC, BioLux Research Ltd, BAROnova Inc. and Bigfoot Biomedical Inc. /Asante Solutions, Inc. Mr. Kern holds a B.S. in Mechanical Engineering Technology from Oregon Institute of Technology. Eyenovia also announced that independent director Julia Haller, MD is stepping down from the company's Board of Directors. Upon her departure, Eyenovia's Board will be reduced to seven seats from eight.